Re-evaluating the generation of a "proteasome-independent" MHC class I-restricted CD8 T cell epitope

Journal of Immunology

Volumn 176, Issue 4, 2006, Pages 2249-2261

  Wherry, E John ^a,b   Golovina, Tatiana N ^a   Morrison, Susan E ^a   Sinnathamby, Gomathinayagam ^a   McElhaugh, Michael J ^a   Shockey, David C ^a   Eisenlohr, Laurence C ^a,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WISTAR INSTITUTE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; BLEOMYCIN HYDROLASE; BUTABINDIDE; CYTOSOL AMINOPEPTIDASE; ENZYME INHIBITOR; EPITOPE; LACTACYSTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDASE; PROTEASOME; PROTEASOME INHIBITOR; PROTEINASE; PUROMYCIN; THYMET OLIGOPEPTIDASE; TRIPEPTIDYL PEPTIDASE II; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL FREE SYSTEM; CELL STRAIN L 929; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SPECIFICITY; FIBROBLAST; GEL FILTRATION; GENETIC TRANSFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE;

EID: 32044465271     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.4.2249     Document Type: Article

References (59)

1. Niedermann, G., E. Geier, M. Lucchiari-Hartz, N. Hitziger, A. Ramsperger, and K. Eichmann. 1999. The specificity of proteasomes: impact on MHC class I processing and presentation of antigens. Immunol. Rev. 172: 29-48.
2. Rock, K. L., and A. L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Anna. Rev. Immunol. 17: 739-779.
3. Stoltze, L., A. K. Nussbaum, A. Sijts, N. P. Emmerich, P. M. Kloetzel, and H. Schild. 2000. The function of the proteasome system in MHC class I antigen processing. Immunol. Today 21: 317-319.
4. Kisselev, A. F., T. N. Akopian, V. Castillo, and A. L. Goldberg. 1999. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Mol. Cell 4: 395-402.
5. Saveanu, L., D. Fruci, and P. van Endert. 2002. Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases. Mol. Immunol. 39: 203-215.
6. + T lymphocytes. Mol. Immunol. 39: 235-247.
7. Craiu, A., T. Akopian, A. Goldberg, and K. Rock. 1997. Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc. Natl. Acad. Sci. USA 94: 10850-10855.
8. Lopez, D., and M. Del Val. 1997. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation. J. Immunol. 159: 5769-5772.
9. Mo, X. Y., P. Cascio, K. Lemerise, A. L. Goldberg, and K. Rock. 1999. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. J. Immunol. 163: 5851-5859.
10. Serwold, T., S. Gaw, and N. Shastri. 2001. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat. Immunol. 2: 644-651.
11. Saric, T., S. C. Chang, A. Hattori, I. A. York, S. Markant, K. L. Rock, M. Tsujimoto, and A. L. Goldberg. 2002. An IFN-γ-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat. Immunol. 3: 1169-1176.
12. York, I. A., S. C. Chang, T. Saric, J. A. Keys, J. M. Favreau, A. L. Goldberg, and K. L. Rock. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3: 1177-1184.
13. Saveanu, L., O. Carroll, V. Undo, M. Del Val, D. Lopez, Y. Lepelletier, F. Greer, L. Schomburg, D. Fruci, G. Niedermann, and P. M. van Endert. 2005. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat. Immunol. 6: 689-697.
14. Yellen-Shaw, A., J. Wherry, G. C. Dubois, and L. Eisenlohr. 1997. Point mutation flanking a CTL epitope ablates recognition of a full-length viral protein. J. Immunol. 158: 3227-3234.
15. Golovina, T. N., E. J. Wherry, T. N. Bullock, and L. C. Eisenlohr. 2002. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum. J. Immunol. 168: 2667-2675.
16. Vinitsky, A., L. Anton, H. Snyder, M. Orlowski, J. Bennink, and J. Yewdell. 1997. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors. J. Immunol. 159: 554-564.
17. Luckey, C. J., G. M. King, J. A. Marto, S. Venketeswaran, B. F. Maier, V. L. Crotzer, T. A. Colella, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 1998. Proteasome can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J. Immunol. 161: 112-121.
18. Anton, L., H. Snyder, J. Bennink, A. Vinitsky, M. Orlowski, A. Porgador, and J. Yewdell. 1998. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. J. Immunol. 160: 4859-4868.
19. Valmori, D., U. Gileadi, C. Servis, P. R. Dunbar, J. C. Cerottini, P. Romero, V. Cerundolo, and F. Levy. 1999. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3. J. Exp. Med. 189: 895-906.
20. Sewell, A. K., D. A. Price, H. Teisserenc, B. L. Booth, Jr., U. Gileadi, F. M. Flavin, J. Trowsdale, R. E. Phillips, and V. Cerundolo. 1999. IFN-γ exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase. J. Immunol. 162: 7075-7079.
21. Luckey, C. J., J. A. Marto, M. Partridge, E. Hall, F. M. White, J. D. Lippolis, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 2001. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors. J. Immunol. 167: 1212-1221.
22. + T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation. J. Immunol. 166: 6164-6169.
23. Dick, T. P., A. K. Nussbaum, M. Deeg, W. Heinemeyer, M. Groll, M. Schirle, W. Keilholz, S. Stevanovic, D. H. Wolf, R. Huber, et al. 1998. Contribution of proteasomal β-subunits to the cleavage of peptide substrates analyzed with yeast mutants. J. Biol. Chem. 273: 25637-25646.
24. Niedermann, G., S. Butz, H. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteosome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2: 289-299.
25. Glas, R., M. Bogyo, J. McMaster, M. Gaczynska, and H. Ploegh. 1998. A proteolytic system that compensates for loss of proteasome function. Nature 392: 618-622.
26. Geier, E., G. Pfeifer, M. Wilm, M. Lucchiari-Hartz, W. Baumeister, K. Eichmann, and G. Niedermann. 1999. A giant protease with potential to substitute for some functions of the proteasome. Science 283: 978-981.
27. Balow, R. M., U. Ragnarsson, and O. Zetterqvist. 1983. Tripeptidyl aminopeptidase in the extralysosomal fraction of rat liver. J. Biol. Chem. 258: 11622-11628.
28. Balow, R., B. Tomkinson, U. Ragnarsson, and O. Zetterqvist. 1986. Purification, substrate specificity, and classification of tripeptidyl peptidase II. J. Biol. Chem. 261: 2409-2417.
29. Wang, E. W., B. M. Kessler, A. Borodovsky, B. F. Cravatt, M. Bogyo, H. L. Ploegh, and R. Glas. 2000. Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase - activity. Proc. Natl. Acad. Sci. USA 97: 9990-9995.
30. Seifert, U., C. Maranon, A. Shmueli, J. F. Desoutter, L. Wesoloski, K. Janek, P. Henklein, S. Drescher, M. Andrieu, H. de la Salle, et al. 2003. An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat. Immunol. 4: 375-379.
31. Reits, E., J. Neijssen, C. Herberts, W. Benckhuijsen, L. Janssen, J. W. Drijfhout, and J. Neefjes. 2004. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20: 495-506.
32. Levy, F., L. Burri, S. Morel, A. L. Peitrequin, N. Levy, A. Bachi, U. Hellman, B. J. Van den Eynde, and C. Servis. 2002. The final N-terminal trimming of a subaminoterminal proline-containing HLA class I-restricted antigenic peptide in the cytosol is mediated by two peptidases. J. Immunol. 169: 4161-4171.
33. Beninga, J., K. L. Rock, and A. L. Goldberg. 1998. Interferon γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J. Biol. Chem. 273: 18734-18742.
34. Portaro, F. C., M. D. Gomes, A. Cabrera, B. L. Fernandes, C. L. Silva, E. S. Ferro, L. Juliano, and A. C. de Camargo. 1999. Thimet oligopeptidase and the stability of MHC class I epitopes in macrophage cytosol. Biochem. Biophys. Res. Commun. 255: 596-601.
35. Silva, C. L., F. C. Portaro, V. L. Bonato, A. C. de Camargo, and E. S. Ferro. 1999. Thimet oligopeptidase (EC 3.4.24.15), a novel protein on the route of MHC class I antigen presentation. Biochem. Biophys. Res. Commun. 255: 591-595.
36. Stoltze, L., M. Schirle, G. Schwarz, C. Schroter, M. W. Thompson, L. B. Hersh, H. Kalbacher, S. Stevanovic, H. G. Rammensee, and H. Schild. 2000. Two new proteases in the MHC class I processing pathway. Nat. Immunol. 1: 413-418.
37. Wherry, E. J., K. A. Puorro, A. Porgador, and L. C. Eisenlohr. 1999. The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained. J. Immunol. 163: 3735-3745.
38. Wherry, E. J., D. Rajagopal, and L. C. Eisenlohr. 2001. Use of vaccinia virus expression vectors to investigate antigen processing and presentation. Methods Mol. Biol. 156: 89-109.
39. Bogyo, M., J. McMaster, M. Gaczynska, D. Tortorella, A. Goldberg, and H. Ploegh. 1997. Covalent modification of the active site threonine of proteasomal β subunits and the Escherichia coli homolog HsIV by a new class of inhibitors. Proc. Natl. Acad. Sci. USA 94: 6629-6634.
40. Bosserhoff, A., J. Wallach, and R. W. Frank. 1989. Micropreparative separation of peptides derived from sodium dodecyl sulphate-solubilized proteins. J. Chromatogr. 473: 71-77.
41. Draenert, R., S. Le Gall, K. J. Pfafferott, A. J. Leslie, P. Chetty, C. Brander, E. C. Holmes, S. C. Chang, M. E. Feeney, M. M. Addo, et al. 2004. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J. Exp. Med. 199: 905-915.
42. Tomkinson, B., L. Grehn, B. Fransson, and O. Zetterqvist. 1994. Use of a dehydroalanine-containing peptide as an efficient inhibitor of tripeptidyl peptidase 11. Arch. Biochem. Biophys. 314: 276-279.
43. + T cell memory in response to low, high, and excessive levels of epitope. J. Immunol. 168: 4455-4461.
44. Bullock, T. N. J., and L. Eisenlohr. 1996. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J. Exp. Med. 184: 1319-1329.
45. Yellen-Shaw, A., C. Laughlin, R. Metrione, and L. Eisenlohr. 1997. Murine transporter associated with antigen presentation (TAP) preferences influence class I-restricted T cell responses. J. Exp. Med. 186: 1655-1662.
46. Rock, K., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-771.
47. Warburton, M. J., and F. Bernardini. 2002. Tripeptidyl peptidase-I is essential for the degradation of sulphated cholecystokinin-8 (CCK-8S) by mouse brain lysosomes. Neurosci. Lett. 331: 99-102.
48. Macpherson, E., B. Tomkinson, R. M. Balow, S. Hoglund, and O. Zetterqvist. 1987. Supramolecular structure of tripeptidyl peptidase II from human erythrocytes as studied by electron microscopy, and its correlation to enzyme activity. Biochem. J. 248: 259-263.
49. York, I. A., A. X. Mo, K. Lemerise, W. Zeng, Y. Shen, C. R. Abraham, T. Saric, A. L. Goldberg, and K. L. Rock. 2003. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity 18: 429-440.
50. Princiotta, M. F., U. Schubert, W. Chen, J. R. Bennink, J. Myung, C. M. Crews, and J. W. Yewdell. 2001. Cells adapted to the proteasome inhibitor 4-hydroxy-5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival. Proc. Natl. Acad. Sci. USA 98: 513-518.
51. Gaczynska, M., and P. A. Osmulski. 2005. Small-molecule inhibitors of proteasome activity. Methods Mol. Biol. 301: 3-22.
52. Serwold, T., F. Gonzalez, J. Kim, R. Jacob, and N. Shastri. 2002. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419: 480-483.
53. Groettrup, M., A. Soza, M. Eggers, L. Kuehn, T. Dick, H. Schild, H. Rammensee, U. Koszinowski, and P. Kloetzel. 1996. A role for the proteasome regulator PA28-α in antigen presentation. Nature 381: 166-168.
54. Schultz, E. S., J. Chapiro, C. Lurquin, S. Claverol, O. Burlet-Schiltz, G. Warnier, V. Russo, S. Morel, F. Levy, T. Boon, et al. 2002. The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome. J. Exp. Med. 195: 391-399.
55. van Hall, T., A. Sijts, M. Camps, R. Offringa, C. Melief, P. M. Kloetzel, and F. Ossendorp. 2000. Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28. J. Exp. Med. 192: 483-494.
56. Serwold, T., S. Gaw, and N. Shastri. 2001. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat. Immunol. 2: 644-651.
57. Kisselev, A. F., T. N. Akopian, and A. L. Goldberg. 1998. Range of sizes of peptide products generated during degradation of different proteins by archaeal proteasomes. J. Biol. Chem. 273: 1982-1989.
58. Kisselev, A. F., T. N. Akopian, K. M. Woo, and A. L. Goldberg. 1999. The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes: implications for understanding the degradative mechanism and antigen presentation. J. Biol. Chem. 274: 3363-3371.
59. Andre, P., M. Groettrup, P. Klenerman, R. de Giuli, B. L. Booth, Jr., V. Cerundolo, M. Bonneville, F. Jotereau, R. M. Zinkernagel, and V. Lotteau. 1998. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc. Natl. Acad. Sci. USA 95: 13120-13124.